RANI Stock Summary and Trading Ideas (Rani Therapeutics Hldgs | NASDAQ:RANI)

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Rani Therapeutics Hldgs trades on the NASDAQ stock market under the symbol RANI.

As of January 14, 2026, RANI stock price declined to $1.40 with 801,781 million shares trading.

RANI has a beta of 1.85, meaning it tends to be more sensitive to market movements. RANI has a correlation of 0.04 to the broad based SPY ETF.

RANI has a market cap of $136.56 million. This is considered a Micro Cap stock.

Last quarter Rani Therapeutics Hldgs reported $0 in Revenue and -$.12 earnings per share. This fell short of revenue expectation by $-4 million and missed earnings estimates by -$.01.

In the last 3 years, RANI traded as high as $8.75 and as low as $.39.

The top ETF exchange traded funds that RANI belongs to (by Net Assets): VTI, VXF, IWC, IBBQ, BIB.

RANI has underperformed the market in the last year with a return of +7.7%, while SPY returned +19.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in RANI shares. However, RANI has outperformed the market in the last 3 month and 2 week periods, returning +198.8% and +3.7%, while SPY returned +3.8% and -0.1%, respectively. This indicates RANI has been having a stronger performance recently.

RANI support price is $1.36 and resistance is $1.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RANI shares will trade within this expected range on the day.